BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 23261753)

  • 21. Monocyte chemoattractant protein-1 alters expression of tight junction-associated proteins in brain microvascular endothelial cells.
    Song L; Pachter JS
    Microvasc Res; 2004 Jan; 67(1):78-89. PubMed ID: 14709405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha4beta1 integrin mediates the recruitment of immature dendritic cells across the blood-brain barrier during experimental autoimmune encephalomyelitis.
    Jain P; Coisne C; Enzmann G; Rottapel R; Engelhardt B
    J Immunol; 2010 Jun; 184(12):7196-206. PubMed ID: 20483748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diapedesis of mononuclear cells across cerebral venules during experimental autoimmune encephalomyelitis leaves tight junctions intact.
    Wolburg H; Wolburg-Buchholz K; Engelhardt B
    Acta Neuropathol; 2005 Feb; 109(2):181-90. PubMed ID: 15549331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanisms involved in T cell migration across the blood-brain barrier.
    Engelhardt B
    J Neural Transm (Vienna); 2006 Apr; 113(4):477-85. PubMed ID: 16550326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spatiotemporal resolution of spinal meningeal and parenchymal inflammation during experimental autoimmune encephalomyelitis.
    Shrestha B; Jiang X; Ge S; Paul D; Chianchiano P; Pachter JS
    Neurobiol Dis; 2017 Dec; 108():159-172. PubMed ID: 28844788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial α6β4 integrin protects during experimental autoimmune encephalomyelitis-induced neuroinflammation by maintaining vascular integrity and tight junction protein expression.
    Welser JV; Halder SK; Kant R; Boroujerdi A; Milner R
    J Neuroinflammation; 2017 Nov; 14(1):217. PubMed ID: 29121970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different segments of the cerebral vasculature reveal specific endothelial specifications, while tight junction proteins appear equally distributed.
    Hanske S; Dyrna F; Bechmann I; Krueger M
    Brain Struct Funct; 2017 Apr; 222(3):1179-1192. PubMed ID: 27435201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E- and P-selectin are not required for the development of experimental autoimmune encephalomyelitis in C57BL/6 and SJL mice.
    Döring A; Wild M; Vestweber D; Deutsch U; Engelhardt B
    J Immunol; 2007 Dec; 179(12):8470-9. PubMed ID: 18056394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels.
    Vajkoczy P; Laschinger M; Engelhardt B
    J Clin Invest; 2001 Aug; 108(4):557-65. PubMed ID: 11518729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulsatility and high shear stress deteriorate barrier phenotype in brain microvascular endothelium.
    Garcia-Polite F; Martorell J; Del Rey-Puech P; Melgar-Lesmes P; O'Brien CC; Roquer J; Ois A; Principe A; Edelman ER; Balcells M
    J Cereb Blood Flow Metab; 2017 Jul; 37(7):2614-2625. PubMed ID: 27702879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneity of the blood-brain barrier.
    Wilhelm I; Nyúl-Tóth Á; Suciu M; Hermenean A; Krizbai IA
    Tissue Barriers; 2016; 4(1):e1143544. PubMed ID: 27141424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Claudin-5 controls intercellular barriers of human dermal microvascular but not human umbilical vein endothelial cells.
    Kluger MS; Clark PR; Tellides G; Gerke V; Pober JS
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):489-500. PubMed ID: 23288152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE.
    Bennett J; Basivireddy J; Kollar A; Biron KE; Reickmann P; Jefferies WA; McQuaid S
    J Neuroimmunol; 2010 Dec; 229(1-2):180-91. PubMed ID: 20832870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Astrocytic tight junctions control inflammatory CNS lesion pathogenesis.
    Horng S; Therattil A; Moyon S; Gordon A; Kim K; Argaw AT; Hara Y; Mariani JN; Sawai S; Flodby P; Crandall ED; Borok Z; Sofroniew MV; Chapouly C; John GR
    J Clin Invest; 2017 Aug; 127(8):3136-3151. PubMed ID: 28737509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Administration of an antagonist of P2X7 receptor to EAE rats prevents a decrease of expression of claudin-5 in cerebral capillaries.
    Grygorowicz T; Dąbrowska-Bouta B; Strużyńska L
    Purinergic Signal; 2018 Dec; 14(4):385-393. PubMed ID: 30091000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood-brain barrier alterations in the cerebral cortex in experimental autoimmune encephalomyelitis.
    Errede M; Girolamo F; Ferrara G; Strippoli M; Morando S; Boldrin V; Rizzi M; Uccelli A; Perris R; Bendotti C; Salmona M; Roncali L; Virgintino D
    J Neuropathol Exp Neurol; 2012 Oct; 71(10):840-54. PubMed ID: 23001217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caveolin1 Is Required for Th1 Cell Infiltration, but Not Tight Junction Remodeling, at the Blood-Brain Barrier in Autoimmune Neuroinflammation.
    Lutz SE; Smith JR; Kim DH; Olson CVL; Ellefsen K; Bates JM; Gandhi SP; Agalliu D
    Cell Rep; 2017 Nov; 21(8):2104-2117. PubMed ID: 29166603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tight junctions contain oligomeric protein assembly critical for maintaining blood-brain barrier integrity in vivo.
    McCaffrey G; Staatz WD; Quigley CA; Nametz N; Seelbach MJ; Campos CR; Brooks TA; Egleton RD; Davis TP
    J Neurochem; 2007 Dec; 103(6):2540-55. PubMed ID: 17931362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RGMa Participates in the Blood-Brain Barrier Dysfunction Through BMP/BMPR/YAP Signaling in Multiple Sclerosis.
    Zhang L; Tang S; Ma Y; Liu J; Monnier P; Li H; Zhang R; Yu G; Zhang M; Li Y; Feng J; Qin X
    Front Immunol; 2022; 13():861486. PubMed ID: 35664003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutrophils mediate blood-spinal cord barrier disruption in demyelinating neuroinflammatory diseases.
    Aubé B; Lévesque SA; Paré A; Chamma É; Kébir H; Gorina R; Lécuyer MA; Alvarez JI; De Koninck Y; Engelhardt B; Prat A; Côté D; Lacroix S
    J Immunol; 2014 Sep; 193(5):2438-54. PubMed ID: 25049355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.